
Bupivicaine is a longer acting amide anesthetic and is useful for longer procedures. Bupivicaine is typically found in 0.25% and 0.5% solutions with and without epinephrine. The maximum dose of 0.25% solution is 2 mg/kg (0.8 ml/kg, maximum dose of 40 ml in a 70.kg adult) Duration of action for bupivicaine is 2-6 hours.
Bupivicaine is not approved for children <12 years old. Toxic effects of bupivicaine are similar to those lidocaine but bupivicaine can be more cardiotoxic. There is higher risk of toxicity from bupivicaine in infants because the primary serum protein it is bound by, alpha1-acid-glycoprotein, is found at lower levels in infants (Hsu). |